NewAmsterdam Pharma Company N.V. Share Price Nasdaq
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.8 USD | -0.30% | +3.02% | +77.26% |
Sales 2024 * | 8.6M 9.3M 776M | Sales 2025 * | 6.3M 6.8M 568M | Capitalization | 1.64B 1.78B 148B |
---|---|---|---|---|---|
Net income 2024 * | -209M -226M -18.86B | Net income 2025 * | -139M -150M -12.54B | EV / Sales 2024 * | 191 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 261 x |
P/E ratio 2024 * |
-7.83
x | P/E ratio 2025 * |
-12.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +3.02% | ||
Current month | +5.60% | ||
1 month | -7.61% | ||
3 months | -15.49% | ||
6 months | +100.81% | ||
Current year | +77.26% |
Date | Price | Change |
---|---|---|
12/24/12 | 19.8 | -0.30% |
11/24/11 | 19.86 | +0.91% |
10/24/10 | 19.68 | +1.97% |
07/24/07 | 19.3 | -1.53% |
06/24/06 | 19.6 | +1.98% |
Delayed Quote Nasdaq, June 13, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.93% | 124B | |
+17.01% | 109B | |
-7.23% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.79% | 16.61B | |
-37.63% | 16.43B | |
+2.17% | 13.4B | |
+24.42% | 11.47B |
- Stock Market
- Equities
- NAMS Stock
- NAMS Stock